Evidence from studies of HCC 23, lung cancer 16, 19, ovarian cancer 20 and endometrial cancer 18 has indicated that PDK4 functions as a tumor suppressor, whereas PDK4 exerts pro-tumorigenic effects in colorectal cancer 15, prostate cancer24 and bladder cancer25. Here, PDK4 is linked to ovarian carcinoma.